Similar articles

• Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis.

  Pelkonen O, Nebert DW. Pelkonen O, et al. Pharmacol Rev. 1982 Jun;34(2):189-222. Pharmacol Rev. 1982. PMID: 6287505 Review. No abstract available.
• Metabolism and activation of carcinogenic polycyclic hydrocarbons by human mammary cells.

  MacNicoll AD, Easty GC, Neville AM, Grover PL, Sims P. MacNicoll AD, et al. Biochem Biophys Res Commun. 1980 Aug 29;95(4):1599-606. doi: 10.1016/s0006-291x(80)80081-7. Biochem Biophys Res Commun. 1980. PMID: 6774726 No abstract available.
• Preferential binding of polycyclic hydrocarbons to matrix-bound DNA in rat-liver nuclei.

  Mironov NM, Grover PL, Sims P. Mironov NM, et al. Carcinogenesis. 1983;4(2):189-93. doi: 10.1093/carcin/4.2.189. Carcinogenesis. 1983. PMID: 6297824
• Polycyclic aromatic hydrocarbon oxidation during prostaglandin biosynthesis.

  Marnett LJ. Marnett LJ. Life Sci. 1981 Aug 10;29(6):531-46. doi: 10.1016/0024-3205(81)90431-8. Life Sci. 1981. PMID: 6268915 Review. No abstract available.
• Oxidative metabolism of polycyclic aromatic hydrocarbons to ultimate carcinogens.

  Levin W, Wood A, Chang R, Ryan D, Thomas P, Yagi H, Thakker D, Vyas K, Boyd C, Chu SY, Conney A, Jerina D. Levin W, et al. Drug Metab Rev. 1982;13(4):555-80. doi: 10.3109/03602538209011087. Drug Metab Rev. 1982. PMID: 6290166 Review. No abstract available.